Skip to main content
HEAL logo

Global X - HealthTech ETF (HEAL) Fund Overview

Educational signal · not a buy or sell recommendation · How to read this

$28.88 -$0.0814 (-0.28%)
Vol: 2.5K|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 17, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Global X - HealthTech ETF (HEAL) trades at $28.88. Global X HealthTech ETF (HEAL) aims to provide investors exposure to companies poised to benefit from advancements in healthcare technology. Sector: Healthcare.

Price as of · Last analyzed: Mar 17, 2026
Global X HealthTech ETF (HEAL) aims to provide investors exposure to companies poised to benefit from advancements in healthcare technology. The fund invests at least 80% of its assets in securities within its underlying index, focusing on exchange-listed companies.

Analyst Coverage for HEAL: HEAL does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the HEAL film Every key number, told as a short cinematic story — just press play. ~2 min

Global X - HealthTech ETF (HEAL) Healthcare & Pipeline Overview

Global X HealthTech ETF (HEAL) offers targeted exposure to companies driving innovation in healthcare technology. By tracking an index of exchange-listed companies, HEAL provides a focused investment vehicle for those seeking to capitalize on the growth and advancements within the rapidly evolving healthtech sector.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for HEAL?

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

The investment thesis for Global X HealthTech ETF (HEAL) centers on the anticipated growth and innovation within the healthcare technology sector. As healthcare systems globally face increasing pressures to improve efficiency, reduce costs, and enhance patient outcomes, the adoption of technology-driven solutions is expected to accelerate. HEAL provides a targeted investment vehicle to capitalize on this trend. The fund's non-diversified strategy offers concentrated exposure to companies leading the way in areas such as telehealth, digital diagnostics, and AI-powered healthcare solutions. A potential catalyst is the increasing regulatory support and investment in healthcare technology infrastructure, which could further drive adoption and growth within the sector. However, investors should be aware of the potential risks, including regulatory hurdles, technological obsolescence, and competitive pressures within the healthtech landscape.

Based on FMP financials and quantitative analysis

HEAL Key Highlights

AI-written as of Mar 17, 2026 — figures and tone reflect the data available then, not today's score.

HEAL's investment strategy focuses on allocating at least 80% of its total assets into companies within the underlying index, providing concentrated exposure to the healthtech sector.

  • The fund is non-diversified, which allows for potentially higher returns but also increases risk compared to more diversified ETFs.
  • HEAL's performance is directly tied to the growth and innovation within the healthcare technology industry, making it sensitive to sector-specific trends and developments.
  • As an ETF, HEAL offers investors a liquid and accessible way to invest in a basket of healthtech companies without having to individually select and manage those investments.
  • HEAL's expense ratio represents the cost of managing the fund, which investors may want to evaluate when evaluating its potential returns.

What Are HEAL's Key Strengths?

Targeted exposure to a high-growth sector.

  • Transparent and rules-based investment approach.
  • Liquidity and accessibility of an ETF structure.

What Are HEAL's Weaknesses?

Non-diversified investment strategy increases risk.

  • Performance is highly dependent on the healthtech sector.
  • Subject to management fees and expenses.

What Are the Key Risks for HEAL?

Regulatory hurdles and data privacy concerns.

  • Rapid technological changes and obsolescence.
  • Competitive pressures from established healthcare companies and new entrants.

What Threats Does HEAL Face?

  • Regulatory changes and healthcare policy shifts.
  • Technological obsolescence and disruption.
  • Competitive pressures within the healthtech industry.

What Are HEAL's Competitive Advantages?

  • Expertise in identifying and tracking relevant healthcare technology companies.
  • Established index methodology for selecting and weighting portfolio holdings.
  • Brand recognition and distribution network of the ETF provider.

What Does HEAL Do?

Global X HealthTech ETF (HEAL) is designed to capture the potential growth within the healthcare technology sector. The fund operates by tracking an underlying index composed of exchange-listed companies that are expected to benefit from advancements and applications in healthcare technology. HEAL employs a non-diversified investment strategy, concentrating its investments in a select group of companies. The fund's core investment principle is to allocate at least 80% of its total assets, in addition to any borrowings used for investment purposes, into the securities that constitute the underlying index. This focused approach allows investors to target their exposure specifically to the healthcare technology industry, which encompasses a range of innovations from telehealth and digital health records to advanced medical devices and biotechnology solutions. By concentrating on companies at the forefront of these technological advancements, HEAL seeks to deliver returns that reflect the growth and innovation within the healthtech space.

What Products and Services Does HEAL Offer?

  • Invests in exchange-listed companies positioned to benefit from healthcare technology advancements.
  • Tracks an underlying index focused on healthtech companies.
  • Allocates at least 80% of its assets to securities within the index.
  • Provides investors with targeted exposure to the healthtech sector.
  • Offers a non-diversified investment strategy.
  • Aims to capture growth potential within the healthcare technology industry.

How Does HEAL Make Money?

  • Generates revenue through management fees charged to investors.
  • Tracks a specific index of healthcare technology companies.
  • Rebalances portfolio to maintain alignment with the underlying index.

What Industry Does HEAL Operate In?

Global X HealthTech ETF (HEAL) operates within the rapidly evolving healthcare technology industry. This sector is characterized by increasing adoption of digital health solutions, driven by factors such as aging populations, rising healthcare costs, and technological advancements. The competitive landscape includes a mix of established healthcare companies, technology giants, and innovative startups, all vying for market share. HEAL's focus on exchange-listed companies positions it to capture the growth of more mature and established players within the healthtech space.

Who Are HEAL's Key Customers?

  • Individual investors seeking exposure to the healthtech sector.
  • Institutional investors looking for targeted healthcare technology investments.
  • Financial advisors seeking to diversify client portfolios with healthtech exposure.
Model self-rating on this text: 66% (not a measure of the evidence) Updated: Mar 17, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● Price is current
  • ● No filing on record
  • ● No analyst coverage
  • ● This is an etf, not an operating company

MoonshotScore History

Recorded daily since 2026-08-23 · 41 snapshots

2026-08-23 44
2026-08-31 44
2026-09-08 44
2026-09-16 44
2026-09-24 44
2026-10-04 44

What changed?

The score has stayed at 44.

Over the same 30 days the stock moved -2.5%.

HEAL Financials

Bull Case vs Bear Case

Bull Case

  • Targeted exposure to a high-growth sector.
  • Transparent and rules-based investment approach.
  • Liquidity and accessibility of an ETF structure.
  • Ongoing: Increasing adoption of telehealth and remote patient monitoring.

Bear Case

  • Non-diversified investment strategy increases risk.
  • Performance is highly dependent on the healthtech sector.
  • Subject to management fees and expenses.
  • Potential: Regulatory hurdles and data privacy concerns.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

HEAL Latest News

HEAL Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for HEAL.

Price Targets

Wall Street price target analysis for HEAL.

HEAL MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for HEAL; grades run from A+ (80-100) to F (below 30).

HEAL Healthcare Stock FAQ

What do analysts say about HEAL stock?

Generally, analysts covering ETFs like HEAL focus on factors such as the fund's expense ratio, tracking error, and exposure to specific sectors or industries. They also assess the growth prospects and risks associated with the underlying holdings. Investors may want to evaluate these factors, as well as their own investment objectives and risk tolerance, when evaluating HEAL.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • The information provided is based on publicly available sources and current market conditions.
  • Investment decisions should be made after consulting with a qualified financial advisor.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis